Multiple Myeloma /

Round 3: What is the Optimal Class of Agents for Triple Class Refractory MM?_Sagar Lonial, MD, FACP and Saad Usmani, MD, MBA, FACP

24:44

Multiple Myeloma

Multiple Myeloma Similar Videos

Similar Videos

Module 2_BCMA-Targeted CAR T-cells

24:20
Module 1_Introduction and Rationale for Targeting BCMA on MM Cells

10:45
New Approvals and Advanced Targets in MM_Joshua Richter, MD

49:01

ABOUT

Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.

The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.

CONNECT

support@bioascend.com

(888) 476-9129

980 North Michigan Avenue, Suite 1400, Chicago, IL 60611